Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

Abroad (travel likely)RecruitingPHASE1

Conditions

Hepatic Impairment · Cirrhosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Inland Empire Clinical Trials, Rialto, California, United States
Contact: Study coordinator (Amanda Benavides) · abenavides@ieliverfoundation.com · 909-883-2999
Orange County Research Center, Tustin, California, United States
Contact: Study coordinator (Melanie Goerlitz) · Melanie.goerlitz@ocresearchcenter.com · 714-550-9990
CenExel Research Centers of America, Hollywood, Florida, United States
Floridian Clinical Research, Miami Lakes, Florida, United States
Contact: Study coordinator (Julio Lopez) · jlopez@floridiancr.com · 305-330-9977
Texas Liver Institute, San Antonio, Texas, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

Hepatic Impairment · Cirrhosis · Cholestatic Liver Disease

Abroad (travel likely)RecruitingPHASE1

Indianapolis, United States

A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)

Hepatic Impairment (HI)

Abroad (travel likely)RecruitingPHASE1

Miami, United States · Orlando, United States

A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

Healthy Adult Participants · Hepatic Impairment (HI)

Abroad (travel likely)RecruitingPHASE1

Bengbu, China

A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function

Healthy Participants · Participants With Mild Hepatic Impairment · Participants With Moderate Hepatic Impairment

Abroad (travel likely)RecruitingPHASE1

Suzhou, China